A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Nilay Shah, MD
Nationwide Children's Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital of Alabama/uab
Birmingham, Alabama, United States
Recruiting - Children'S Hospital of Colorado
Aurora, Colorado, United States
Recruiting - Children'S National Medical Center
Washington D.C., District of Columbia, United States
Recruiting - Children'S Hospital at Montefiore
The Bronx, New York, United States
Recruiting - Nationwide Children'S Hospital
Columbus, Ohio, United States
Nilay Shah, MDRecruiting - Primary Children'S Hospital
Salt Lake City, Utah, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Jul 2022
- Primary completion
- 31 Jul 2026
- Completion
- 31 Dec 2029
- Last update posted
- 12 Aug 2025
- Registered enrollment
- 86
- Registry id
- NCT05135975
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.